'AQURO', a new, potentially automatable approach for quatifying mitral regurgitation: technology development and validation through collaboration between cardiovascular science and bioengineering

ISRCTN ISRCTN14627513
DOI https://doi.org/10.1186/ISRCTN14627513
Secondary identifying numbers 7355
Submission date
18/06/2010
Registration date
18/06/2010
Last edited
27/08/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Miss Michaela Moraldo
Scientific

St Mary's Hospital
International Centre for Circulatory Health
Praed Street
London
W2 1NY
United Kingdom

Email m.moraldo@imperial.ac.uk

Study information

Study designSingle-centre non-randomised interventional diagnosis trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeDiagnostic
Scientific title
Study acronymDRN 373 (AQURO)
Study objectivesStable subjects with mitral regurgitation previously diagnosed on echocardiography will be recruited from the outpatient service of Imperial College Healthcare NHS Trust. We will follow the standard British Society of Echocardiography protocol, and then add additional views. The standard protocol involves ultrasound recordings in different positions around the heart. Each complete echocardiography appointment will take approximately 40 minutes. All calculations made from the recorded images will occur later, after the patient has left.
Ethics approval(s)MREC approved (ref: 08/H0707/71)
Health condition(s) or problem(s) studiedTopic: Diabetes Research Network; Subtopic: Type 2; Disease: Cardiovascular disease
InterventionPatients are recruited and ultrasound scans are performed for about 40 minutes to be analysed and compared with the standard technique.

Study entry: registration only
Intervention typeOther
Primary outcome measureEffective regurgitant orifice area (EROA), measured during 40 minutes of acquisition
Secondary outcome measuresNot provided at time of registration
Overall study start date23/03/2009
Completion date23/03/2012

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsPlanned sample size: 50; UK sample size: 50
Key inclusion criteriaStable subjects with mitral regurgitation previously diagnosed on echocardiography
Key exclusion criteria1. Atrial fibrillation
2. Moderate or severe disease of tricuspid or pulmonary valves
3. Any aortic valve disease graded mild or higher
4. Prosthetic aortic valve and body habitus or coexistent disease that precludes satisfactory imaging quality
Date of first enrolment23/03/2009
Date of final enrolment23/03/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

St Mary's Hospital
London
W2 1NY
United Kingdom

Sponsor information

Imperial College Healthcare NHS Trust (UK)
Hospital/treatment centre

International Centre for Circulatory Health
59 North Wharf Road
London
W2 1LA
England
United Kingdom

Website http://www.imperial.nhs.uk/
ROR logo "ROR" https://ror.org/056ffv270

Funders

Funder type

Charity

British Heart Foundation (BHF) (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
the_bhf, The British Heart Foundation, BHF
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2013 Yes No